Marco Antonio Biamonte
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$5.2MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $5.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 31, 2025 | NIH | SBIR Phase II Ultrasensitive, High-Specificity Rapid Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis | $842K | BIG EYE DIAGNOSTICS INC |
| Jul 23, 2025 | NIH | SBIR Phase II Supporting WHO Lymphatic Filariasis Elimination Programs: Progressing a Highly Sensitive and Specific Rapid Diagnostic Test for Brugia Species Infection to Commercialization Readiness | $397K | BIG EYE DIAGNOSTICS INC |
| Jul 12, 2024 | NIH | SBIR Phase II Ultrasensitive, High-Specificity Rapid Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis | $853K | BIG EYE DIAGNOSTICS INC |
| Apr 25, 2024 | NIH | SBIR Phase II Supporting WHO Lymphatic Filariasis Elimination Programs: Progressing a Highly Sensitive and Specific Rapid Diagnostic Test for Brugia Species Infection to Commercialization Readiness | $797K | BIG EYE DIAGNOSTICS INC |
| Mar 7, 2024 | NIH | SBIR Phase II SUPPORTING WHO ONCHOCERCIASIS ELIMINATION PROGRAMS: PROGRESSING A HIGHLY SENSITIVE AND ULTRA-SPECIFIC RAPID DIAGNOSTIC TEST TO COMMERCIALIZATION READINESS | $908K | BIG EYE DIAGNOSTICS INC |
| Mar 16, 2023 | NIH | SBIR Phase II SUPPORTING WHO ONCHOCERCIASIS ELIMINATION PROGRAMS: PROGRESSING A HIGHLY SENSITIVE AND ULTRA-SPECIFIC RAPID DIAGNOSTIC TEST TO COMMERCIALIZATION READINESS | $921K | BIG EYE DIAGNOSTICS INC |
| Sep 14, 2022 | NIH | SBIR Phase I First-in-class, highly sensitive and specific rapid diagnostic test to detect Paragonimus infections | $258K | BIG EYE DIAGNOSTICS INC |
| Apr 15, 2022 | NIH | SBIR Phase II Ultrasensitive, High-Specificity Rapid Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis | $260K | BIG EYE DIAGNOSTICS INC |
Peer ranks
Federal funding#263
Awards as PI#216
Patents#505
Companies
- BIG EYE DIAGNOSTICS INCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.